Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Berkshire Hathaway Inc | 55 |
| 2 | L'Oréal SA | 37 |
| 3 | Symrise AG | 32 |
| 4 | Pfizer Inc | 31 |
| 5 | Thermo Fisher Scientific Inc | 27 |
| 6 | AbbVie Inc | 25 |
| 7 | Toshiba Corp | 24 |
| 8 | Procter and Gamble Co | 23 |
| 9 | Fiore Holding SRL | 22 |
| 10 | Chinese Academy of Sciences | 21 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 565 |
| 2 | A61P | Therapeutic activity (drug indications) | 368 |
| 3 | A61Q | Cosmetics, personal care | 224 |
| 4 | C07J | 159 | |
| 5 | C08L | Polymer compositions (blends) | 69 |
| 6 | A61L | Sterilising / disinfecting materials | 59 |
| 7 | G01N | Investigating / analysing materials | 48 |
| 8 | A01N | Preservation of bodies; biocides; pest repellents | 41 |
| 9 | C08B | 41 | |
| 10 | C08G | Polymers from non-vinyl bonds (e.g. polyamides, polyesters) | 37 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Cleansing articles for skin and/or hair which also deposit skin care actives | 2002 | Procter and Gamble Co | 355 |
| Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses | 2013 | Yarrow Bioscience Inc | 175 |
| Cleansing and conditioning article for skin or hair | 2000 | Procter and Gamble Co | 350 |
| Esters of hyaluronic acid | 1989 | Fiore Holding SRL | 396 |
| AH RECEPTOR ANTAGONISTS | 2007 | Symrise AG | 160 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2022 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Bertrand Liagre | Université de Limoges | 5 |
| 2 | Cécile Corbière | Université de Limoges | 4 |
| 3 | Jean‐Louis Beneytout | Université de Limoges | 3 |
| 4 | Guoping Cai | University Town of Shenzhen | 2 |
| 5 | Yukihiro Shoyama | Nagasaki International University | 2 |
| 6 | Pascale Vergne‐Salle | Hôpital Dupuytren | 2 |
| 7 | Scott W. Nelson | Iowa State University | 2 |
| 8 | Hua Zhou | University Town of Shenzhen | 2 |
| 9 | Naili Wang | Shenyang Pharmaceutical University | 2 |
| 10 | Yaou Zhang | University Town of Shenzhen | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Identification of intra-group, inter-individual, and gene-specific variances in mRNA expression profiles in the rheumatoid arthritis synovial membrane | 2008 | 115 | Rheumatoid Arthritis Research and Therapies |
| Structure–function relationship for saponin effects on cell cycle arrest and apoptosis in the human 1547 osteosarcoma cells: a molecular modelling approach of natural molecules structurally close to diosgenin | 2004 | 97 | Natural product bioactivities and synthesis |
| A novel glucosyltransferase involved in steroid saponin biosynthesis in Solanum aculeatissimum | 2005 | 81 | Natural product bioactivities and synthesis |
| UDP-GLUCURONOSYLTRANSFERASE 1A4 POLYMORPHISMS IN A JAPANESE POPULATION AND KINETICS OF CLOZAPINE GLUCURONIDATION | 2005 | 77 | Pharmacogenetics and Drug Metabolism |
| In vivo anthelmintic activity of an aqueous extract from sisal waste (Agave sisalana Perr.) against gastrointestinal nematodes in goats | 2010 | 49 | Parasites and Host Interactions |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of (25R)-5alpha-Spirostan-3beta-ol?
Which companies hold the most patents involving this compound?
What is the patent landscape trend for this compound in recent years?
Which research institutions have published the most on this compound?
What are the primary patent classification areas for this compound?